SNPs in DNA repair genes, such as XPC rs2228001 and PARP1 rs1805414, can serve as valuable biomarkers for guiding pre‐operative risk assessment and post‐operative surveillance in CCA patients. This evidence concerns the gene XPC and cholangiocarcinoma.